Kun Liao

1.0k total citations · 1 hit paper
15 papers, 701 citations indexed

About

Kun Liao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kun Liao has authored 15 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kun Liao's work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (3 papers). Kun Liao is often cited by papers focused on RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (3 papers). Kun Liao collaborates with scholars based in China, Hong Kong and United States. Kun Liao's co-authors include Huai‐Qiang Ju, Rui‐Hua Xu, Junzhong Lin, Zexian Liu, Qi‐Nian Wu, Hai‐Yu Mo, Kai Yu, Jin‐Fei Lin, Xiaojun Zheng and Heng‐Ying Pu and has published in prestigious journals such as Nature Communications, Molecular Cell and PLoS ONE.

In The Last Decade

Kun Liao

13 papers receiving 699 citations

Hit Papers

Phosphorylated NFS1 weake... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Liao China 11 423 215 156 127 123 15 701
Wenlian Xie China 18 384 0.9× 266 1.2× 178 1.1× 133 1.0× 94 0.8× 57 1.0k
Grant M. Fischer United States 9 274 0.6× 164 0.8× 135 0.9× 172 1.4× 109 0.9× 26 617
Corinna Seliger Germany 16 344 0.8× 235 1.1× 70 0.4× 190 1.5× 51 0.4× 44 809
Yinyun Ni China 11 243 0.6× 143 0.7× 128 0.8× 143 1.1× 92 0.7× 22 646
Chun Gong China 18 631 1.5× 185 0.9× 89 0.6× 268 2.1× 43 0.3× 30 1.0k
Bahman Sadeghi Iran 9 281 0.7× 209 1.0× 79 0.5× 147 1.2× 94 0.8× 32 696
Chensi Ouyang United States 7 515 1.2× 347 1.6× 171 1.1× 259 2.0× 165 1.3× 15 998
Changsong Zhang China 16 446 1.1× 169 0.8× 88 0.6× 169 1.3× 53 0.4× 48 718
Miriam Butler Australia 11 246 0.6× 100 0.5× 83 0.5× 72 0.6× 54 0.4× 28 530

Countries citing papers authored by Kun Liao

Since Specialization
Citations

This map shows the geographic impact of Kun Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Liao more than expected).

Fields of papers citing papers by Kun Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Liao. The network helps show where Kun Liao may publish in the future.

Co-authorship network of co-authors of Kun Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Liao. A scholar is included among the top collaborators of Kun Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Liao. Kun Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Wang, Yiyu, Jin‐Fei Lin, Wen‐Wei Wu, et al.. (2025). Inhibition of MBTPS1 enhances antitumor immunity and potentiates anti-PD-1 immunotherapy. Nature Communications. 16(1). 4047–4047.
3.
Lin, Jin‐Fei, Zexian Liu, Dongliang Chen, et al.. (2025). Nucleus-translocated GCLM promotes chemoresistance in colorectal cancer through a moonlighting function. Nature Communications. 16(1). 263–263. 4 indexed citations
4.
Cai, Zerong, Di Chen, Haojie Chen, et al.. (2024). Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints. EMBO Molecular Medicine. 16(12). 3089–3112. 5 indexed citations
5.
Tian, Tian, Yongqiang Zheng, Hai‐Yu Mo, et al.. (2023). The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer. Nature Communications. 14(1). 6690–6690. 44 indexed citations
6.
Han, Yi, Yanyu Zhang, Xiaojun Zheng, et al.. (2023). IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance. Molecular Cell. 83(11). 1887–1902.e8. 73 indexed citations
7.
Lin, Jin‐Fei, Peishan Hu, Yiyu Wang, et al.. (2022). Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Signal Transduction and Targeted Therapy. 7(1). 54–54. 226 indexed citations breakdown →
8.
Lu, Yun‐Xin, Wei Chen, Zixian Wang, et al.. (2022). Arginine methylation of MTHFD1 by PRMT5 enhances anoikis resistance and cancer metastasis. Oncogene. 41(32). 3912–3924. 27 indexed citations
9.
Cai, Zerong, Yan Hu, Kun Liao, et al.. (2022). Circular RNAs: Emerging regulators of glucose metabolism in cancer. Cancer Letters. 552. 215978–215978. 23 indexed citations
10.
Li, Ting, Yan‐Xing Chen, Xiaojun Zheng, et al.. (2022). Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts. Gut. 72(3). 501–511. 135 indexed citations
11.
Dai, Ziwei, Li‐Yan Xu, Kun Liao, et al.. (2019). Identification of Cancer–associated metabolic vulnerabilities by modeling multi-objective optimality in metabolism. Cell Communication and Signaling. 17(1). 124–124. 20 indexed citations
12.
Ye, Zengjie, Hong Zhong Qiu, Mu Zi Liang, et al.. (2017). Effect of a mentor-based, supportive-expressive program, Be Resilient to Breast Cancer, on survival in metastatic breast cancer: a randomised, controlled intervention trial. British Journal of Cancer. 117(10). 1486–1494. 71 indexed citations
13.
Ye, Zengjie, Mei Ling Liu, Zhang Zhang, et al.. (2017). Psychometric properties of the Chinese version of the Parent Perception of Uncertainty Scale (PPUS) among parents of children with cancer diagnosis. International Journal of Nursing Sciences. 4(3). 278–284. 11 indexed citations
14.
Liao, Kun, Bin Xia, Mengjun Hou, et al.. (2015). Parthenolide Inhibits Cancer Stem-Like Side Population of Nasopharyngeal Carcinoma Cells via Suppression of the NF-κB/COX-2 Pathway. Theranostics. 5(3). 302–321. 46 indexed citations
15.
Chen, Huifeng, Jianxin Wan, Yanfang Gao, et al.. (2013). Role of a Novel Functional Variant in the PPP2R1A Promoter on the Regulation of PP2A-Aalpha and the Risk of Hepatocellular Carcinoma. PLoS ONE. 8(3). e59574–e59574. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026